Terms: = Cervical cancer AND HMGA2, HMGI-C, 8091, ENSG00000149948, LIPO, HMGIC, BABL AND Treatment
4 results:
1. Verapamil modulates NFAT2 to inhibit tumor growth and potentiates PD1ab immune checkpoint inhibitor therapy in cervical cancer treatment.
Liao YQ; Fang BB; Wu QX; Dong WY; Deng GM
J Recept Signal Transduct Res; 2023 Aug; 43(4):93-101. PubMed ID: 38070127
[TBL] [Abstract] [Full Text] [Related]
2. Low-molecular-mass secretome profiling identifies hmga2 and MIF as prognostic biomarkers for oral cavity squamous cell carcinoma.
Chang KP; Lin SJ; Liu SC; Yi JS; Chien KY; Chi LM; Kao HK; Liang Y; Lin YT; Chang YS; Yu JS
Sci Rep; 2015 Jul; 5():11689. PubMed ID: 26138061
[TBL] [Abstract] [Full Text] [Related]
3. Salvage chemotherapy in recurrent cervical cancer with biweekly pegylated liposomal Doxorubicin (lipo-dox).
Chen JR; Yang YC; Chen TC; Lai JC; Chang SJ; Chang CL; Wang KL
Taiwan J Obstet Gynecol; 2008 Sep; 47(3):322-6. PubMed ID: 18935997
[TBL] [Abstract] [Full Text] [Related]
4. Incomplete excision of cervical intraepithelial neoplasia and risk of treatment failure: a meta-analysis.
Ghaem-Maghami S; Sagi S; Majeed G; Soutter WP
Lancet Oncol; 2007 Nov; 8(11):985-93. PubMed ID: 17928267
[TBL] [Abstract] [Full Text] [Related]
